These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18569332)

  • 21. Design and synthesis of novel series of 5-HT6 receptor ligands having indole, a central aromatic core and 1-amino-4 methyl piperazine as a positive ionizable group.
    Hayat F; Cho S; Rhim H; Indu Viswanath AN; Pae AN; Lee JY; Choo DJ; Choo HY
    Bioorg Med Chem; 2013 Sep; 21(17):5573-82. PubMed ID: 23810425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3-(4-Fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT(2A) receptor antagonists.
    Rowley M; Hallett DJ; Goodacre S; Moyes C; Crawforth J; Sparey TJ; Patel S; Marwood R; Patel S; Thomas S; Hitzel L; O'Connor D; Szeto N; Castro JL; Hutson PH; MacLeod AM
    J Med Chem; 2001 May; 44(10):1603-14. PubMed ID: 11334570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimization of (arylpiperazinylbutyl)oxindoles exhibiting selective 5-HT₇ receptor antagonist activity.
    Volk B; Gacsályi I; Pallagi K; Poszávácz L; Gyönös I; Szabó E; Bakó T; Spedding M; Simig G; Szénási G
    J Med Chem; 2011 Oct; 54(19):6657-69. PubMed ID: 21859099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rigidized 1-aryl sulfonyl tryptamines: synthesis and pharmacological evaluation as 5-HT6 receptor ligands.
    Nirogi R; Dwarampudi A; Kambhampati R; Bhatta V; Kota L; Shinde A; Badange R; Jayarajan P; Bhyrapuneni G; Dubey PK
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4577-80. PubMed ID: 21724392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and pharmacological evaluation of conformationally restricted N-arylsulfonyl-3-aminoalkoxy indoles as a potential 5-HT6 receptor ligands.
    Nirogia RV; Kambhampati R; Daulatabad AV; Gudla P; Shaikh M; Achanta PK; Shinde AK; Dubey PK
    J Enzyme Inhib Med Chem; 2011 Jun; 26(3):341-9. PubMed ID: 21524149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New tetrahydrobenzindoles as potent and selective 5-HT(7) antagonists with increased In vitro metabolic stability.
    Kikuchi C; Suzuki H; Hiranuma T; Koyama M
    Bioorg Med Chem Lett; 2003 Jan; 13(1):61-4. PubMed ID: 12467617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and pharmacological activity of metabolites of the 5-HT(4) receptor antagonist SB-207266.
    Fedouloff M; Hossner F; Voyle M; Ranson J; Powles J; Riley G; Sanger G
    Bioorg Med Chem; 2001 Aug; 9(8):2119-28. PubMed ID: 11504648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1-Sulfonyl-6-Piperazinyl-7-Azaindoles as potent and pseudo-selective 5-HT6 receptor antagonists.
    Fabritius CH; Pesonen U; Messinger J; Horvath R; Salo H; Gałęzowski M; Galek M; Stefańska K; Szeremeta-Spisak J; Olszak-Płachta M; Buda A; Adamczyk J; Król M; Prusis P; Sieprawska-Lupa M; Mikulski M; Kuokkanen K; Chapman H; Obuchowicz R; Korjamo T; Jalava N; Nowak M
    Bioorg Med Chem Lett; 2016 Jun; 26(11):2610-5. PubMed ID: 27117428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel 5-HT6 receptor antagonists/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia.
    Kołaczkowski M; Marcinkowska M; Bucki A; Śniecikowska J; Pawłowski M; Kazek G; Siwek A; Jastrzębska-Więsek M; Partyka A; Wasik A; Wesołowska A; Mierzejewski P; Bienkowski P
    Eur J Med Chem; 2015 Mar; 92():221-35. PubMed ID: 25557493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3-(4-Piperidinyl)- and 3-(8-aza-bicyclo[3.2.1]oct-3-yl)-2-phenyl-1H-indoles as bioavailable h5-HT2A antagonists.
    Crawforth J; Goodacre S; Maxey R; Bourrain S; Patel S; Marwood R; O'Connor D; Herbert R; Hutson P; Rowley M
    Bioorg Med Chem Lett; 2000 Dec; 10(24):2701-3. PubMed ID: 11133072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solid-phase synthesis of 2,3-disubstituted indoles: discovery of a novel, high-affinity, selective h5-HT2A antagonist.
    Smith AL; Stevenson GI; Lewis S; Patel S; Castro JL
    Bioorg Med Chem Lett; 2000 Dec; 10(24):2693-6. PubMed ID: 11133070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N1-(Benzenesulfonyl)tryptamines as novel 5-HT6 antagonists.
    Tsai Y; Dukat M; Slassi A; MacLean N; Demchyshyn L; Savage JE; Roth BL; Hufesein S; Lee M; Glennon RA
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2295-9. PubMed ID: 11055342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and SAR of 3-arylsulfonyl-pyrazolo[1,5-a]pyrimidines as potent serotonin 5-HT6 receptor antagonists.
    Ivachtchenko AV; Golovina ES; Kadieva MG; Kysil VM; Mitkin OD; Tkachenko SE; Okun I
    Bioorg Med Chem; 2011 Feb; 19(4):1482-91. PubMed ID: 21277782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine/serotonin receptor ligands. Part IV [1]: synthesis and pharmacology of novel 3-benzazecines and 3-benzazonines as potential 5-HT2A and dopamine receptor ligands.
    El-Subbagh H; Wittig T; Decker M; Elz S; Nieger M; Lehmann J
    Arch Pharm (Weinheim); 2002 Nov; 335(9):443-8. PubMed ID: 12447918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis and pharmacological evaluation of indolylsulfonamide amines as potent and selective 5-HT6 receptor antagonists.
    Nirogi RV; Bandyala TR; Reballi V; Konda JB; Daulatabad AV; Khagga M
    J Enzyme Inhib Med Chem; 2015 Feb; 30(1):85-97. PubMed ID: 24666297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1-(Arylsulfonyl)-2,3-dihydro-1H-quinolin-4-one derivatives as 5-HT(6) serotonin receptor ligands.
    Park CM; Choi JI; Choi JH; Kim SY; Park WK; Seong CM
    Bioorg Med Chem Lett; 2011 Jan; 21(2):698-703. PubMed ID: 21190848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and pharmacological characteristics of novel (Z)-3-arylidene-indolin-2(1H)-ones: preliminary results.
    Mokrosz MJ; Charakchieva-Minol S; Kozioł A; Kłodzińska A; Chojnacka-Wójcik E
    Pol J Pharmacol; 2000; 52(1):47-50. PubMed ID: 10949120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-activity relationship of 5-chloro-2-methyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole analogues as 5-HT(6) receptor agonists.
    Mattsson C; Svensson P; Boettcher H; Sonesson C
    Eur J Med Chem; 2013 May; 63():578-88. PubMed ID: 23542166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aminotriazines with indole motif as novel, 5-HT
    Kułaga D; Jaśkowska J; Satała G; Latacz G; Śliwa P
    Bioorg Chem; 2020 Nov; 104():104254. PubMed ID: 32919133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and characterization of the first fluorescent antagonists for human 5-HT4 receptors.
    Berque-Bestel I; Soulier JL; Giner M; Rivail L; Langlois M; Sicsic S
    J Med Chem; 2003 Jun; 46(13):2606-20. PubMed ID: 12801225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.